Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

By S. Bellentani, G. Saccoccio, F. Masutti, Lory Croc, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli. Annals of Internal Medicine, 2000

1,354 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/ba22cae1886ff5da669eb01369a6853b829f76f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Z. Younossi
2. Q. Anstee
3. C. Day
4. A. Sanyal
5. S. Bellentani
6. J. Clark
7. A. Baranova
8. Amalia Gastaldelli

In Epidemiology

1. Z. Younossi
2. S. Bellentani
3. Q. Anstee
4. C. Day
5. A. Sanyal
6. V. Ratziu
7. J. Clark
8. Giulio Marchesini

In Pathology and Forensic Medicine

1. Z. Younossi
2. S. Bellentani
3. Q. Anstee
4. A. Sanyal
5. J. Clark
6. A. Baranova
7. C. Day
8. Amalia Gastaldelli

Citations in the corpus

• Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels (2002, background): “These findings were not unexpected; the prominent role of fat accumulation in inducing chronic liver disease has been previously assessed in the general population (20, 28) and in patients with overt hepatic dysfunction (9, 10).”
• A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010, background): “) and a daily alcohol consumption 620 g in women and 30 g in men, based on epidemiological studies showing that alcohol-induced steatosis can occur above these thresholds [2].”
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (2011, background): “For example, in heavy drinkers, obesity increases the risk for steatosis by twofold.(86)”
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values (2003, methodology): “A retrospective study was performed to (1) characterize the clinical and histologic features of those with nonalcoholic fatty liver disease (NAFLD) and normal alanine aminotransferase (ALT) values, (2) compare the spectrum of NAFLD associated with normal versus elevated ALT levels, and (3) determine”
• Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005, result): “Similar prevalence data have been obtained in Japanese [5] and Italian [6] populations.”
• Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. (2019, background): “6-fold higher relative risk in obese (Dionysos study) [64].”
• Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss (2009, neutral): “503 % carbohydrate 52 (2) 54 (3) 54 (2) 55 (2) 0.”
• The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults (2006, background): “A second study looked at a subset of the Dionysos population (N = 257) in a case-control type design, and looked at the prevalence of steatosis in relation to body weight and alcohol consumption.(27) Other causes of liver disease, in particular viral hepatitis and medications, were excluded.”